Technetium Tc 99m tilmanocept fails to detect sentinel lymph nodes in endometrial cancer

BACKGROUND: Technetium Tc 99m tilmanocept is a synthetic radiotracer specifically designed for sentinel lymph node (SLN) mapping that has been FDA-approved in breast cancer, melanoma, and head and neck cancer. No published studies exist for the use of this radiotracer in endometrial cancer. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Ravali A., Moon, Ashley S., Chow, Stephanie, Heilbroner, Lucas, Howitt, Brooke, Diver, Elisabeth, Dorigo, Oliver, Litkouhi, Babak, Renz, Malte, Karam, Amer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361318/
https://www.ncbi.nlm.nih.gov/pubmed/35958955
http://dx.doi.org/10.1016/j.gore.2022.101054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361318/
https://www.ncbi.nlm.nih.gov/pubmed/35958955
http://dx.doi.org/10.1016/j.gore.2022.101054

Ejemplares similares